Cukierman & Co. Investment House

Founded in 1993, Cukierman & Co. Investment House Ltd is the leading European focused investment house, headquartered in Israel. We provide a full array of investment banking services including Corporate Finance, Private Equity, Family office and Strategic Consulting to Israeli and European companies.

Since its establishment, Cukierman & Co. has been engaged in transactions valued at €3B through Private Placements, Initial Public Offerings and Mergers and Acquisitions. In addition, Cukierman & Co. has developed a dominant position in Private Equity through the Catalyst Fund.

Cukierman & Co. will continue to be a different breed of investment bank. Our strong international network, responsiveness and multifaceted investment team combine to make Cukierman & Co., a leading provider of sound and innovative growth strategies.

Cukierman & Co. Life Sciences (CLS) was established in 2006 as the Life Sciences Corporate Finance arm of Cukierman &Co. Investment House Ltd.

Cukierman & Co. Life Sciences (CLS) is a leading specialist investment banking group delivering high quality, senior level advice to the global Life Sciences Sectors for value-added Corporate Partnering, M&A and Equity Financing Transactions.

Cukierman & Co. Life Sciences mission is to assist:

• Healthcare companies in identifying, negotiating and closing strategic partnerships, M&A transactions and financings
• Venture Capital and Private Equity in selecting, valuating, acquiring/divesting products, businesses and companies in the life sciences sector.

CLS is an international provider of high level, independent expertise in corporate, scientific and commercial due diligence and in financial valuation and transaction process management.

Financial Communication
Investor Relations
Analyst coverage

Mergers and acquisitions
Sell side
Buy side
Reverse mergers
Divestitures

Business development: access to key industry players
In- and out-licensing
Strategic R&D partnership
Asset acquisition and sales
Deal strategy, structuring & negotiation
Transaction management

Management & Investor consultancy: access to global expertise and operational solutions

Interim management
Company set-up, restructuring and governance
Scientific and business functions

Due diligence
Technology R&D and Portfolio analysis
Business models and plans
Governance & Management

Business Intelligence
Ecosystem analysis platform

Corporate, Marketing and Regulatory Affairs Strategy

CLS offers financial services and management consulting to emergent as well as established companies active in the following fields:

• Pharmaceuticals
• Biotechnology
• Diagnostics
• Medical Devices
• Nutraceuticals

Broad understanding of healthcare marketplace and individual sub-sectors enables us to address corporate concerns and build relationships among all stakeholders including commercial, academia, public, investor community and regulatory authorities. The CLS healthcare practice differentiates itself from competitors through strategic value at executive and board level.

CLS added-value builds industry knowledge and worldwide contact network in healthcare and on intimate relationships with global investor base, including Venture Capital firms, corporate VCs, private equity funds, asset management, institutional investors and family offices with life sciences expertise.

.